Receptor tyrosine kinase

Results: 281



#Item
1Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

Add to Reading List

Source URL: www.cancer.dk

Language: English - Date: 2016-03-02 01:55:24
22014  Annual Report Centre for Cancer Biology

2014 Annual Report Centre for Cancer Biology

Add to Reading List

Source URL: www.centreforcancerbiology.org.au

Language: English - Date: 2015-07-16 03:15:51
3Pharmacological Research–803  Contents lists available at ScienceDirect Pharmacological Research journal homepage: www.elsevier.com/locate/yphrs

Pharmacological Research–803 Contents lists available at ScienceDirect Pharmacological Research journal homepage: www.elsevier.com/locate/yphrs

Add to Reading List

Source URL: www.brimr.org

Language: English - Date: 2016-08-03 14:58:15
4Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U

Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U

Add to Reading List

Source URL: lvdmaaten.github.io

Language: English - Date: 2016-07-16 15:30:43
5ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

Add to Reading List

Source URL: www.zailaboratory.com

Language: English - Date: 2015-11-24 01:50:17
6PRESS RELEASE  Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

Add to Reading List

Source URL: www.oncodesign.com

Language: English - Date: 2016-07-12 12:51:48
7M i ch a e l P h am 5019 Frink Ave| San Diego, CA 92117| ( |  Accomplishments Identification and confirmation of Janus Kinase 2 (Jak2) directly phosphorylating metabolic regulator kina

M i ch a e l P h am 5019 Frink Ave| San Diego, CA 92117| ( | Accomplishments Identification and confirmation of Janus Kinase 2 (Jak2) directly phosphorylating metabolic regulator kina

Add to Reading List

Source URL: venturabiocenter.com

Language: English - Date: 2015-12-25 20:40:07
8TECHNOLOGY OFFER  A COBALT-BASED STRATEGY FOR TUMOUR TARGETING OF EGFR-INHIBITORS BACKGROUND The development of receptor tyrosine-kinase inhibitors (TKIs) in recent

TECHNOLOGY OFFER A COBALT-BASED STRATEGY FOR TUMOUR TARGETING OF EGFR-INHIBITORS BACKGROUND The development of receptor tyrosine-kinase inhibitors (TKIs) in recent

Add to Reading List

Source URL: techtransfer.univie.ac.at

Language: English - Date: 2015-07-01 06:41:06
905-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

05-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

Add to Reading List

Source URL: www.swogstat.org

Language: English - Date: 2016-08-19 21:10:12
10Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD  April 17th, 2016

Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016

Add to Reading List

Source URL: www.biodesix.com

Language: English - Date: 2016-05-02 01:40:22